Crohn’s & Colitis Congress™

Sessions Speakers Exhibitors Floor Plan Buzz
Search

Sessions (44)

2 - TREATMENT OF PEDIATRIC CROHN’S DISEASE PATIENTS WITH EARLY PERIANAL COMPLICATIONS (Room Bristlecone 4)

18 Jan 18
2:40 PM - 2:50 PM

Tracks: Cutting-Edge Pediatric IBD, Management of Complicated IBD

Speaker(s): Jeremy Adler
BACKGROUND: Among pediatric patients with Crohn disease (CD), the variation in treatment of perianal complications (PaC) has not been characterized... More...

Cutting-Edge Pediatric IBD ($$) (Room Bristlecone 4)

18 Jan 18
1:00 PM - 5:00 PM

Tracks: Cutting-Edge Pediatric IBD, Pre-Congress Workshops

Speaker(s): KT Park MD, MS ; Michael Kappelman MD, MPH ; Neera Gupta MD, MAS
Member Registration Rate: $50 | Non-Member Registration Rate: $100 This inaugural pre-congress workshop is targeted to all providers who ca... More...

3 - ENDOSCOPIC AND HISTOLOGIC SCORES AS PREDICTORS OF PROGRESSION TO COLECTOMY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (Room Bristlecone 4)

18 Jan 18
2:50 PM - 3:00 PM

Tracks: Cutting-Edge Pediatric IBD, Management of Complicated IBD

Speaker(s): Nicole Green
Background: Children with acute severe ulcerative colitis (ASC) often require hospitalization. Colectomy is needed for medically intractable diseas... More...

The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic and Translational Research Workshop (Room Pinyon 3)

18 Jan 18
1:00 PM - 5:00 PM

Tracks: Lloyd Mayer, MD, Young IBD Investigators Workshop, Pre-Congress Workshops

Speaker(s): Benjamin Cohen ; Christina Ha MD ; Florian Rieder MD ; Karen Chachu MD, PhD
Member Registration Rate: $0 | Non-Member Registration Rate: $0 Back by popular demand for its fourth year, this half-day pre-congress work... More...

7 - FRAGMENTED CARE IS PREVALENT AMONG IBD HOSPITALIZATIONS AND IS ASSOCIATED WITH WORSE OUTCOME (Room Pinyon 3)

18 Jan 18
3:05 PM - 3:20 PM

Tracks: Lloyd Mayer, MD, Young IBD Investigators Workshop, Management of Complicated IBD

Speaker(s): Shirley Cohen-Mekelburg
Background: Fragmentation in inpatient care is prevalent among patients with chronic disease and is associated with increased mortality and readmis... More...

Poster Reception (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Poster Session

More...

10 - EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIED SHARED METHYLOMIC CONTRIBUTIONS TO SUSCEPTIBILITY AND PROGRESSION IN PEDIATRIC CROHN'S DISEASE (Room Pinyon 4/5)

19 Jan 18
9:05 AM - 9:15 AM

Tracks: Management of Complicated IBD, Session I

Speaker(s): Hari Somineni
Background: Most Crohn’s Disease (CD) patients present with an inflammatory phenotype (B1), however, a subgroup rapidly progress to complicat... More...

Basic Quick Shots Breakout (Room Pinyon 1/2)

20 Jan 18
8:00 AM - 8:35 AM

Tracks: Session III

Speaker(s): Matthew Grisham
More...

11 - DELAYED ILEAL POUCH ANAL ANASTOMOSIS HAS A LOWER 30-DAY ADVERSE EVENT RATE: ANALYSIS FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (Room Pinyon 4/5)

19 Jan 18
9:15 AM - 9:25 AM

Tracks: Management of Complicated IBD, Session I

Speaker(s): Bharati Kochar
Background: Ulcerative colitis (UC) patients requiring colectomy often have a staged ileal pouch anal anastomosis (IPAA). There are no prospective ... More...

Clincial Quick Shots Breakout (Room Pinyon 4/5)

20 Jan 18
8:00 AM - 8:35 AM

Tracks: Session III

Speaker(s): Meenakshi Bewtra, MD, PhD, MPH
More...

12 - HIGH PATIENT ACTIVATION IS ASSOCIATED WITH CLINICAL REMISSION IN A LONGITUDINAL ANALYSIS OF A LARGE INTERNET BASED COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (Room Pinyon 4/5)

19 Jan 18
9:25 AM - 9:35 AM

Tracks: Management of Complicated IBD, Session I

Speaker(s): Edward Barnes
Background: High levels of patient activation, defined as having the knowledge, skills, and confidence to effectively manage one’s care, has ... More...

P169 - A CASE OF SUCCESSFUL INDUCTION OF REMISSION IN MODERATE-TO-SEVERE STEROID REFRACTORY ULCERATIVE COLITIS USING HERBAL THERAPY (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Mark Mattar
Introduction: The use of Complementary and Alternative Medicine (CAM) is prevalent in patients with ulcerative colitis (UC). Most randomized clinic... More...

P170 - A NOVEL PATIENT REPORTED QUALITY OF LIFE MEASURE CORRELATES WELL WITH THE SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IN A LARGE INTERNET BASED COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Edward Barnes
Background: The Short Inflammatory Bowel Disease Questionnaire (SIBDQ), a validated inflammatory bowel disease (IBD) specific measure of health rel... More...

P171 - AUTOIMMUNE DISORDERS AFTER PROCTOCOLECTOMY IN ULCERATIVE COLITIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Yezaz Ghouri
Introduction: Inflammatory bowel diseases (IBD), along with other immune-mediated disorders are considered as idiopathic disease entities with no c... More...

P172 - CHROMOENDOSCOPY VERSUS HIGH DEFINITION WHITE LIGHT ENDOSCOPY FOR DYSPLASIA DETECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Ramprasad Jegadeesan
Introduction: Current guidelines endorsed by several societies suggest the use of spray chromoendoscopy (CE) to improve dysplasia detection during ... More...

P173 - CLOSTRIDIUM DIFFICILE AND CYTOMEGALOVIRUS COLITIS CO-INFECTION IN PATIENTS WITH STEROID-REFRACTORY ULCERATIVE COLITIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Hoyeon Joo
Introduction The incidence of Ulcerative colitis(UC) in Korea is increasing rapidly. Corticosteroids, immunomodulators and biologic agents used in ... More...

P174 - CLOSTRIDIUM DIFFICILE IN INFLAMMATORY BOWEL DISEASE: WHICH TREATMENT REGIMEN IS SUPERIOR? (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Nikhita Dharbhamulla
Introduction: The incidence of Clostridium difficile infection (CDI) has been rising and its occurrence in Inflammatory Bowel Disease (IBD) is high... More...

P175 - COLORECTAL CANCER RISK IN INFLAMMATORY BOWEL DISEASE FOLLOWING LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Derrick Eichele
Colorectal cancer (CRC) risk in patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) is increased compared to th... More...

P176 - COMPLICATED CROHN’S DISEASE IS ASSOCIATED WITH PERIANAL INVOLVEMENT, IBD-ASSOCIATED SEROLOGIES, AND POLYGENIC RISK SCORES DERIVED FROM IBD-ASSOCIATED VARIANTS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Shishir Dube
Background: In Crohn’s disease (CD), disease severity is categorized by the Montreal classification. More complicated (stricturing and/or pen... More...

P177 - EFFECTS OF PRE-OPERATIVE USE OF BIOLOGIC AGENTS ON INTRA-OPERATIVE BLOOD LOSS, OPERATIVE TIME AND LENGTH OF SMALL BOWEL RESECTION IN CROHN'S DISEASE PATIENTS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Fares Ayoub
Introduction/Background/Aims While the effects of biologic agents on post-operative outcomes in Crohn’s disease patients is well-established,... More...

P178 - EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT C. DIFFICILE INFECTION IN INFLAMMATORY BOWEL DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Raseen Tariq
Background: C. difficile infection (CDI) in Inflammatory bowel disease (IBD) is associated with poor outcomes. Fecal microbiota transplantation (FM... More...

P179 - ELEVEN-YEAR-OLD WITH INFLAMMATORY THORACIC ANEURYSM FOUND AT DIAGNOSIS OF CROHN'S DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Saurabh Talathi
INTRODUCTION: Cardiovascular associations of Crohn’s Disease (CD) are rare and include valvular heart disease, aortitis and aneurysm. We repo... More...

P180 - ENDOSCOPIC CORRECTION OF TWISTED POUCH RELATED STENOSIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Yezaz Ghouri
Introduction: Total proctocolectomy with creation of a pouch using a loop of small bowel followed by Ileal pouch-anal anastomosis (IPAA) is a commo... More...

P181 - ENTERIC INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: ENDOSCOPIC AND HISTOLOGIC FINDINGS DO NOT DIFFERENTIATE INFECTION FROM FLARE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Jordan Axelrad
Background: The similar presentations in relapse of inflammatory bowel disease (IBD) and enteric infection pose substantial barriers to diagnosis a... More...

P182 - EPIDEMIOLOGY OF NEPHROLITHIASIS IN HOSPITALIZED PATIENTS OF INFLAMMATORY BOWEL DISEASE: NATIONAL INPATIENT SAMPLE ANALYSIS 2002-2014 (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Zubair Khan
Background: Extraintestinal manifestations (EIMs) are common in Inflammatory bowel disease (IBD), adding to the burden of disease, with a prevalenc... More...

P183 - IMPACT OF OBESITY ON SHORT- AND INTERMEDIATE-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASES: POOLED ANALYSIS OF PLACEBO ARMS OF INFLIXIMAB CLINICAL TRIALS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Siddharth Singh
Background and Aims: To assess whether obesity may affect natural history of inflammatory bowel diseases (IBD), we conducted an individual particip... More...

P184 - IMPROVING PROCESS OF CARE MEASURES FOR PATIENTS WITH IBD: KEY FINDINGS FROM A QI PILOT (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Michele Rubin APN
Background: Nursing staff within a GI practice can coordinate care around IBD quality measures by checking for bone loss related to corticosteroid ... More...

P185 - INCISIONAL HERNIA REPAIR COMPLICATING INFLAMMATORY BOWEL DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Pramoda Koduru
Background: The incidence of incisional hernia (IH) in inflammatory bowel disease (IBD) ranges from 4-20% due to risk factors such as multiple surg... More...

P186 - OBESITY AND RESPONSE TO INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: POOLED ANALYSIS OF INDIVIDUAL PARTICIPANT DATA FROM CLINICAL TRIALS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Siddharth Singh
Background and Aims: To assess whether obesity may affect response to infliximab, we conducted an individual participant data (IPD) pooled analysis... More...

P187 - POUCH PROLAPSE IN CHILDREN WITH ULCERATIVE COLITIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Teresa Wachs
Background: The majority of children who undergo colectomy for intractable Ulcerative Colitis (UC) receive an ileal pouch anal anastomosis (commonl... More...

P188 - PREGNANCY OUTCOMES IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: A 10-YEAR NATIONWIDE POPULATION-BASED COHORT STUDY (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Han Hee Lee
Background and Aims: Existing data regarding the association between inflammatory bowel disease (IBD) and pregnancy outcomes is lacking in Korea. M... More...

P189 - REAL WORLD EVALUATION OF PROLONGED CLINICAL RESPONSE WITH VEDOLIZUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS TREATED IN A PRIVATE PRACTICE SETTING (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Timothy E. Ritter
Background: Vedolizumab (VDZ), a gut-selective anti-integrin monoclonal antibody, was approved for the treatment of Crohn’s disease (CD) and ... More...

P190 - REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Haridarshan Patel
Background: Immunosuppressives (IM) are often used as maintenance therapy to reduce the risk of relapse in patients with inflammatory bowel disease... More...

P191 - RISING INCIDENCE OF IRON DEFICIENCY ANEMIA AND ASSOCIATED COST OF CARE IN HOSPITALIZED PATIENTS OF INFLAMMATORY BOWEL DISEASE IN USA: NATIONWIDE ANALYSIS 2002-2014 (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Zubair Khan
Background: Extraintestinal complications are common in IBD, and are reported in more than 25% of patients. Anemia is one of the most common manife... More...

P192 - SURGICAL OUTCOMES IN CHILDREN HOSPITALIZED WITH UC RECEIVING INTENSIFIED INFLIXIMAB INDUCTION (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Kendra Francis
Background: Hospitalized children with severe Ulcerative Colitis who are steroid unresponsive often receive Infliximab (IFX). Standard IFX inductio... More...

P193 - THE DEVELOPMENT OF AN IBD SPECIALTY CLINIC WITHIN A GASTROENTEROLOGY PRACTICE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Carrie Mize
Background: Inflammatory bowel disease (IBD) is a chronic disease that has no cure. Patients with inflammatory bowel disease often require frequent... More...

P194 - THE EFFECT OF BIOLOGIC THERAPY ON POST-OPERATIVE COMPLICATIONS IN PEDIATRIC PATIENTS WITH MEDICALLY REFRACTORY INFLAMMATORY BOWEL DISEASE UNDERGOING BOWEL RESECTION IN A TERTIARY CENTER (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Jennifer Mitsuya
Background: There has been limited investigation of pediatric patients with medically refractory inflammatory bowel disease (IBD) who have been tre... More...

P195 - THE GASTROENTEROLOGY LEARNER PATHWAY IN IBD: AN OUTCOMES-BASED ITERATIVE APPROACH TO IBD EDUCATION USING ADVANCED ANALYTICS AND PREDICTIVE MODELING TO SUSTAIN BEHAVIORAL CHANGE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Jacqui Brooks
Background The AGA, RMEI (CME company), and RealCME (technology company), designed and implemented a phased CME continuum in IBD, directed at 17,00... More...

P196 - THE IMPACT OF INFLAMMATORY BOWEL DISEASE SEVERITY ON HEALTH-RELATED QUALITY OF LIFE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Jason Low
Background: Few studies have examined the association between severity of inflammatory bowel disease (IBD) and humanistic burden. The current study... More...

P197 - THROMBOTIC CUTANEOUS GANGRENE: A RARE DERMATOLOGIC AND HEMATOLOGIC EXTRAINTESTINAL MANIFESTATION OF ULCERATIVE COLITIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Michael Yu
Background: Ulcerative colitis (UC) is associated with many extraintestinal manifestations including dermatologic and hematologic involvement. Thro... More...

P198 - TRAINEES IN GASTROENTEROLOGY AND MATERNAL-FETAL MEDICINE HAVE MORE PREGNANCY-RELATED IBD KNOWLEDGE COMPARED WITH TRAINEES IN INTERNAL MEDICINE OR OBSTETRICS-GYNECOLOGY (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Adam Ehrlich
Background: Patients frequently have questions about how IBD influences pregnancy. Both patients and providers should have a clear understanding of... More...

P199 - TREATMENT DISCONTINUATION, FLARES, AND HOSPITALIZATIONS AMONG BIOLOGIC-NAÏVE PATIENTS WITH IBD OVER THE FIRST YEAR OF TREATMENT: A “REAL-WORLD” COMPARATIVE EFFECTIVENESS STUDY OF VEDOLIZUMAB VERSUS INFLIXIMAB (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Haridarshan Patel
Background: The clinical effectiveness of vedolizumab (VDZ), a gut-selective anti-integrin antibody used to treat patients with moderately-to-sever... More...

P200 - TRENDS IN THE INCIDENCE AND OUTCOMES OF ATRIAL FIBRILLATION IN HOSPITALIZED PATIENTS OF INFLAMMATORY BOWEL DISEASE: NATIONWIDE ANALYSIS 2002-2014 (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Zubair Khan
Background: Inflammation plays a role in the development of atrial fibrillation (AF). Thus, inflammatory bowel disease (IBD) may increase the risk ... More...

P201 - USE OF BIOLOGICS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON CHEMOTHERAPY FOR CANCER (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Pramoda Koduru
Background: Management of inflammatory bowel disease (IBD) remains a clinical challenge in patients with active cancer. Observational data have sho... More...

P202 - VACCINATIONS IN IBD PATIENTS: GASTROENTEROLOGISTS’ VS. INTERNISTS’ PRACTICE AND PERCEPTIONS OF RESPONSIBILITY (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Muhammad Hammami
IBD patients (pts) are at increased risk of vaccination-preventable infections. It is not clear whether the gastroenterologists (GI) or primary car... More...

P203 - VEDOLIZUMAB IS SAFE AFTER ANTI-TNF-ASSOCIATED PULMONARY TUBERCULOSIS IN CROHN'S DISEASE: CASE REPORT (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

Tracks: Management of Complicated IBD

Speaker(s): Muhammad Hammami
Anti-TNFα agents increase risk of infections due to systemic immunosuppression. Vedolizumab (VDZ) inhibits adhesions of gut-specific lymphocy... More...

17 - SINGLE-CELL SEQUENCING OF CREEPING FAT IN CROHN’S DISEASE REVEALS DISTINCT IMMUNE CLUSTERS AND CELLULAR RESTRUCTURING IN THE PRESENCE OF LIVE BACTERIA AND FUNGI (Room Pinyon 1/2)

20 Jan 18
8:14 AM - 8:21 AM

Tracks: Management of Complicated IBD, Session III

Speaker(s): Suzanne Devkota
Crohn’s Disease and ulcerative colitis present distinct characteristics, one being the expansion of mesenteric adipose tissue (MAT) surroundi... More...

23 - EMERGENT COLECTOMY RATES DECREASED WHILE ELECTIVE IPAA RATES WERE STABLE OVER TIME: A NATIONWIDE INPATIENT SAMPLE STUDY (Room Pinyon 4/5)

20 Jan 18
8:21 AM - 8:28 AM

Tracks: Management of Complicated IBD, Session III

Speaker(s): Ryan Ungaro
Background: Despite advances in medical therapy for UC, many patients still need surgery. Data on UC colectomy rates in the United States are limit... More...

24 - HIGHER BODY MASS INDEX IS ASSOCIATED WITH INCREASED RISK OF TREATMENT FAILURE AND SURGERY IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS (Room Pinyon 4/5)

20 Jan 18
8:28 AM - 8:35 AM

Tracks: Management of Complicated IBD, Session III

Speaker(s): Soumya Kurnool
Background: Though pharmacokinetic studies suggest accelerated biologic drug clearance with increasing body weight, evidence of obesity’s imp... More...